Sentiment Trading

AstraZeneca PLC announces promising trial results and strategic partnerships, including successful breast cancer and gastric cancer treatments, and a new precision medicine partnership with Danaher Corporation.

AstraZeneca PLC kicked off 2025 with strong financial results, including a 7% increase in product revenue, and strategic collaborations that position the company for future success.